omega-n-methylarginine has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adolfsson, J; Bergerheim, US; Brundin, L; Jansson, OT; Morcos, E; Wiklund, NP | 1 |
| Fonseca, GA; Griffith, OW; Kilbourn, RG; Trissel, LA | 1 |
1 trial(s) available for omega-n-methylarginine and Cancer of Kidney
| Article | Year |
|---|---|
Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
Topics: Adult; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Male; Middle Aged; Nitrates; omega-N-Methylarginine | 2000 |
1 other study(ies) available for omega-n-methylarginine and Cancer of Kidney
| Article | Year |
|---|---|
Nitric oxide synthase activity in human renal cell carcinoma.
Topics: Analysis of Variance; Anticarcinogenic Agents; Arginine; Calcium; Carcinogens; Carcinoma, Renal Cell; Cell Division; Cells, Cultured; Citrulline; DNA; Enzyme Inhibitors; Humans; Interleukin-2; Kidney Neoplasms; Kidney Tubules, Proximal; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Penicillamine; Thymidine; Tumor Cells, Cultured | 1998 |